Literature DB >> 20954138

Life-threatening hypercalcemia in patients with rhabdomyolysis-induced oliguric acute renal failure.

Giorgio Graziani1, Albania Calvetta, David Cucchiari, Serenella Valaperta, Alessandro Montanelli.   

Abstract

BACKGROUND: In a third of patients presenting with rhabdomyolysis-induced acute renal failure (ARF), a biphasic plasma calcium profile may occur.
METHODS: We report a case of rhabdomyolysis-induced ARF presenting hypocalcemia during oliguria, followed by a severe hypercalcemia in the polyuric phase. A hypocalcemia-induced acute increase of plasma parathyroid hormone in the early stage of ARF was followed by a down-regulation of parathyroid hormone, 1,25(OH)2 vitamin D and 25(OH) vitamin D during the renal function recovery, associated with an acute hypercalcemia. The plasma calcium increase induced in our patient severe neurological disturbances, life-threatening short QT interval and Brugada-like syndrome at risk of malignant arrhythmias. This complication was treated by hemodialysis and pamidronic acid infusion.
RESULTS: This case confirms that the pathogenesis of the biphasic calcium profile may be related to the massive calcium uptake in the ischemic muscle cells during oliguria, followed by a muscle calcium release later in the polyuric stage of ARF. Therefore, the behavior of calciotropic hormones may be the consequence rather than the cause of plasma calcium changes.
CONCLUSIONS: We would like to emphasize the danger of sudden death that may occur in the recovery phase of rhabdomyolysis-induced ARF when the physician might be wrongly convinced that the major risks have disappeared.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20954138     DOI: 10.5301/jn.2010.5794

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  6 in total

Review 1.  A "crush" course on rhabdomyolysis: risk stratification and clinical management update for the perioperative clinician.

Authors:  Devan R Cote; Eva Fuentes; Ali H Elsayes; Jonathan J Ross; Sadeq A Quraishi
Journal:  J Anesth       Date:  2020-05-18       Impact factor: 2.078

2.  Bone scintigraphy of severe hypercalcemia following simvastatin induced rhabdomyolysis.

Authors:  Zubair B Mirza; Sophia Hu; Louis F Amorosa
Journal:  Clin Cases Miner Bone Metab       Date:  2017-02-10

Review 3.  Renal Involvement in Idiopathic Inflammatory Myopathies.

Authors:  David Cucchiari; Claudio Angelini
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

4.  Primary hypoparathyroidism accompanied by rhabdomyolysis induced by infection: A case report.

Authors:  Li-Na Ding; Yi Wang; Jun Tian; Li-Fang Ye; Shi Chen; Shi-Min Wu; Wen-Bin Shang
Journal:  World J Clin Cases       Date:  2019-10-06       Impact factor: 1.337

5.  Severe hypercalcemia complicating recovery of acute kidney injury due to rhabdomyolysis.

Authors:  Lisa Aimee Hechanova; Seyed-Ali Sadjadi
Journal:  Am J Case Rep       Date:  2014-09-14

6.  Treatment of extreme hypercalcaemia: the role of haemodialysis.

Authors:  Anna B Basok; Boris Rogachev; Yosef Shmuel Haviv; Marina Vorobiov
Journal:  BMJ Case Rep       Date:  2018-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.